Hospital Virgen del Camino -ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2020

  1. Fe de errores a «Profilaxis farmacológica de la tromboembolia venosa en la prostatectomía radical» [Med Clin (Barc). 2020;154(4):113–118] (Medicina Clinica (2020) 154(4) (113–118), (S0025775319303513), (10.1016/j.medcli.2019.04.023))

    Medicina Clinica

  2. Pharmacological venous thromboembolism prophylaxis in radical prostatectomy

    Medicina Clinica, Vol. 154, Núm. 4, pp. 113-118

2018

  1. Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice

    Clinical and Translational Oncology, Vol. 20, Núm. 7, pp. 862-869

2017

  1. Influence of secondary diagnoses in the development of urinary incontinence after radical prostatectomy

    Archivio Italiano di Urologia e Andrologia, Vol. 89, Núm. 1, pp. 34-38

2016

  1. Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study

    Oral Oncology, Vol. 62, pp. 54-59

2012

  1. Clinical, molecular and biochemical characterization of nine Spanish families with Conradi-Hünermann-Happle syndrome: New insights into X-linked dominant chondrodysplasia punctata with a comprehensive review of the literature

    British Journal of Dermatology, Vol. 166, Núm. 4, pp. 830-838

  2. Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Núm. 26, pp. 10534-10539